2m 2m 2m 2m 2m 2m 2m
TWIST BIOSCIENCE (TWST)
NASDAQ
$86.00+$1.00 (+1.18%)
Price as of Jun 23, 2026 7:12 PM EDT- $5.3BMarket Cap
- 141.07%1-Year Change
- Diagnostics & ResearchIndustry
TWIST BIOSCIENCE (TWST)
$86.00+$1.00 (+1.18%)
Annual
Quarterly
09/30/2025 | 09/30/2024 | 09/30/2023 | 09/30/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 376.6M +20.32% | 313.0M +27.69% | 245.1M +20.41% | 203.6M +53.83% | |
Cost of Revenue | 185.6M +3.31% | 179.6M +15.60% | 155.4M +30.21% | 119.3M +48.02% | |
Gross Profit | 191.0M +43.23% | 133.3M +48.61% | 89.7M +6.52% | 84.2M +62.89% | |
Sales and Marketing Expense | 247.0M +13.09% | 218.4M +15.11% | 189.7M -10.90% | 212.9M +56.69% | |
Research and Development Expense | -80.3M -11.63% | -90.9M -15.01% | -106.9M -11.15% | -120.3M +74.18% | |
Depreciation and Amortization Expense | 24.9M -20.93% | 31.4M +7.24% | 29.3M +77.49% | 16.5M +69.37% | |
Total Operating Expenses | 512.8M -3.93% | 533.8M +15.48% | 462.3M +5.46% | 438.3M +53.77% | |
Operating Profit | -136.3M -38.30% | -220.8M +1.69% | -217.2M -7.50% | -234.8M +53.72% | |
Interest Income | 11.4M -25.94% | 15.3M +6.82% | 14.4M +369.14% | 3.1M +603.91% | |
Interest Expense | N/A N/A | N/A N/A | -5,000 -93.75% | -80,000 -78.20% | |
Interest Income and Expense and Net | 11.4M -25.94% | 15.3M +6.85% | 14.4M +381.56% | 3.0M +4,285.29% | |
Total Nonoperating Income and Expense | -903,000 -65.92% | -2.6M +297.30% | -667,000 -38.64% | -1.1M -20.66% | |
Income before Taxes | -77.0M -63.03% | -208.2M +2.31% | -203.5M -10.87% | -228.3M +48.20% | |
Income Taxes | 719,000 +28.39% | 560,000 -51.39% | 1.2M +111.07% | -10.4M +439.43% | |
Extraordinary Items | 0 -100.00% | 44.9M N/A | N/A N/A | N/A N/A | |
Net Income | -77.7M -62.79% | -208.7M +2.01% | -204.6M -6.08% | -217.9M +43.24% | |
Net Income from Continuing Operations Applicable to Common | -77.0M -63.03% | -208.2M +2.31% | -203.5M -10.87% | -228.3M +48.20% | |
Basic EPS and Net Income | -1.30 -63.89% | -3.60 0.00% | -3.60 -10.89% | -4.04 +28.25% | |
Diluted EPS and Net Income | -1.30 -63.89% | -3.60 0.00% | -3.60 -10.89% | -4.04 +28.25% | |
Basic Weighted Average Shares | 59.8M +3.09% | 58.0M +1.99% | 56.9M +5.57% | 53.9M +11.68% | |
Diluted Weighted Average Shares | 59.8M +3.09% | 58.0M +1.99% | 56.9M +5.57% | 53.9M +11.68% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 183.0M -19.12% | 226.3M -21.00% | 286.5M -24.35% | 378.7M -18.71% | |
Short-Term Investments | 49.4M -1.39% | 50.1M +0.28% | 49.9M -60.45% | 126.3M +949.37% | |
Cash and Cash Equivalents and Short-Term Investments | 232.4M -15.91% | 276.4M -17.84% | 336.4M -33.38% | 505.0M +5.67% | |
Total Current Assets | 333.0M -3.98% | 346.8M -18.26% | 424.3M -28.87% | 596.5M +9.15% | |
Accumulated Depreciation | 95.0M +25.58% | 75.6M +49.33% | 50.7M +59.41% | 31.8M -10.29% | |
Property and Plant and Equipment and Net | 102.3M -0.23% | 102.5M -22.23% | 131.8M -5.46% | 139.4M +216.04% | |
Total Long-Term Assets | 4.9M +58.49% | 3.1M -45.56% | 5.7M +67.83% | 3.4M -55.89% | |
Total Assets | 641.9M +4.48% | 614.3M -20.88% | 776.4M -19.24% | 961.4M +36.93% | |
Income Taxes Payable | 4.5M +66.72% | 2.7M -37.70% | 4.4M +19.48% | 3.7M +50.04% | |
Total Short-Term Debt | N/A N/A | N/A N/A | 0 N/A | 0 -100.00% | |
Total Current Liabilities | 91.4M +28.73% | 71.0M -3.16% | 73.3M -19.13% | 90.7M +43.79% | |
Total Long-Term Debt | 15.0M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 747,000 +83.54% | 407,000 -14.32% | 475,000 +691.67% | 60,000 -98.82% | |
Total Liabilities | 168.9M +19.25% | 141.6M -7.41% | 153.0M -11.06% | 172.0M +41.82% | |
Retained Earnings | -1.3B +6.25% | -1.2B +20.22% | -1.0B +24.70% | -828.4M +35.68% | |
Total Stockholders Equity | 473.0M +0.06% | 472.7M -24.18% | 623.4M -21.02% | 789.4M +35.91% | |
Total Shares Outstanding | 60.6M +2.98% | 58.9M +2.29% | 57.6M +1.83% | 56.5M +14.19% | |
Cash Flow | |||||
Cash from Operating Activities | -47.6M -25.69% | -64.1M -55.01% | -142.5M +14.54% | -124.4M +10.82% | |
Capital Expenditures | 28.0M +451.69% | 5.1M -81.73% | 27.8M -72.73% | 101.9M +276.40% | |
Cash from Investing Activities | -24.8M +706.32% | -3.1M -106.07% | 50.6M +121.73% | -232.9M -249.17% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 28.5M +314.22% | 6.9M +656.31% | 911,000 -99.66% | 270.5M -17.82% | |
Financials Ratio | |||||
Gross Margin | 50.72% +19.04% | 42.61% +16.39% | 36.61% -11.53% | 41.38% +5.89% | |
Operating Margin | -36.18% -48.72% | -70.56% -20.36% | -88.60% -23.18% | -115.33% -0.07% | |
Return on Assets | -12.37% -58.80% | -30.02% +27.46% | -23.55% -10.10% | -26.19% -5.20% | |
Return on Equity | -16.43% -56.87% | -38.08% +31.48% | -28.97% -8.91% | -31.80% -4.13% | |
Revenue Growth | 20.32% -26.61% | 27.69% +35.67% | 20.41% -62.09% | 53.83% +14.84% | |
Current Ratio | 3.64 -25.41% | 4.88 -15.59% | 5.79 -12.05% | 6.58 -24.09% | |
Cash Ratio | 2.00 -37.17% | 3.19 -18.42% | 3.91 -6.46% | 4.18 -43.46% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow